NIH-funded research R21 grant

Immune cell patterns in sarcoidosis

Official title: Multi-Omic Characterization of Immune Cells in Sarcoidosis

Funded at Oklahoma Medical Research Foundation · NIH-11143841 · Data updated 2026-11-12

The project uses gene and protein tests on immune cells to find markers that could help diagnose sarcoidosis and predict how it will behave.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionOklahoma Medical Research Foundation
NIH-funded
Lab location1 site (Oklahoma City, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2025
Award (this year)$127,875
NIH project number5R21HL175092-02
Project IDNIH-11143841 on NIH RePORTER

Who could benefit from this research

Could help

Adults with confirmed or suspected sarcoidosis who can provide blood and/or lung samples — including people of African ancestry — are ideal candidates.

Less likely to help

People without sarcoidosis or those seeking immediate therapeutic benefit are unlikely to gain direct clinical improvement from participating in this biomarker-focused project.

What this research studies

Researchers will collect blood and, when possible, lung or bronchoalveolar lavage samples from people with sarcoidosis to study immune cells. They will apply multiple 'omics' techniques — including genetics, single-cell RNA sequencing, and protein profiling — to capture how immune cells differ between patients. Advanced bioinformatics will combine these data to identify molecular signatures linked to disease severity, organ involvement, and ancestry. The team will compare results to prior genetic findings, with attention to people of African ancestry, to build potential diagnostic or prognostic markers.

Why it matters

Potential benefit: If successful, this work could produce blood- or tissue-based markers to improve sarcoidosis diagnosis and predict which patients may develop more severe or organ-specific disease.

How similar studies have gone: Earlier genetic and single-cell studies in sarcoidosis have identified susceptibility genes and immune cell signals, but fully integrated multi-omic biomarkers for diagnosis and prognosis are still largely unproven.

Where this research is happening

  • Oklahoma Medical Research Foundation
    Oklahoma City, United States
    Active

Researchers

  • Principal investigator: Montgomery, Courtney — Oklahoma Medical Research Foundation
  • Study coordinator: Montgomery, Courtney

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.